investorscraft@gmail.com

Intrinsic ValuePrecision Optics Corporation, Inc. (POCI)

Previous Close$4.98
Intrinsic Value
Upside potential
Previous Close
$4.98

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Precision Optics Corporation, Inc. operates in the specialized optics and photonics industry, providing high-precision optical components and systems for medical, defense, and industrial applications. The company’s core revenue model is driven by custom-designed optical solutions, including endoscopes, imaging systems, and micro-optics, tailored to meet stringent technical requirements. Its expertise in miniaturization and advanced manufacturing positions it as a critical supplier for minimally invasive medical devices and high-performance defense systems. Precision Optics serves niche markets where precision and reliability are paramount, competing with larger players through agility and technical specialization. The company’s focus on R&D and partnerships with OEMs underscores its role as an innovator in optical technology, though its smaller scale limits broad market penetration. Its market positioning hinges on delivering high-value, low-volume products that command premium pricing due to their specialized nature.

Revenue Profitability And Efficiency

Precision Optics reported revenue of $19.1 million for FY 2024, reflecting its niche market focus. However, the company posted a net loss of $2.95 million, with diluted EPS of -$0.49, indicating ongoing profitability challenges. Operating cash flow was negative at $2.68 million, exacerbated by capital expenditures of $0.27 million, highlighting inefficiencies in converting revenue to cash. The lack of dividend payments aligns with its reinvestment priorities.

Earnings Power And Capital Efficiency

The company’s negative earnings and cash flow underscore weak earnings power, likely due to high R&D and operational costs relative to its revenue base. Capital efficiency appears strained, with limited free cash flow generation. The diluted EPS of -$0.49 further emphasizes the need for improved scalability or cost management to achieve sustainable profitability.

Balance Sheet And Financial Health

Precision Optics holds $0.41 million in cash and equivalents against $3.43 million in total debt, signaling liquidity constraints. The debt-heavy balance sheet raises concerns about financial flexibility, particularly given negative operating cash flow. Shareholder equity is likely under pressure, though specific figures are unavailable. The company’s financial health appears fragile, necessitating careful monitoring of debt obligations.

Growth Trends And Dividend Policy

Revenue growth trends are unclear without prior-year comparisons, but the net loss suggests stagnant or declining margins. The absence of dividends reflects a reinvestment strategy, though the lack of profitability limits growth funding options. The company’s future growth may hinge on expanding its customer base or securing higher-margin contracts in its specialized markets.

Valuation And Market Expectations

With a negative EPS and weak cash flow, traditional valuation metrics are challenging to apply. Market expectations likely center on turnaround potential, given its niche expertise. The stock’s valuation may reflect speculative interest in its optical technology rather than near-term earnings prospects.

Strategic Advantages And Outlook

Precision Optics’ strategic advantage lies in its technical expertise and niche market focus, but financial instability poses significant risks. The outlook depends on improving operational efficiency and securing stable, high-margin contracts. Success in medical or defense applications could drive long-term value, though near-term challenges remain acute.

Sources

Company filings (CIK: 0000867840), FY 2024 preliminary data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount